Remove Assay Development Remove DNA Remove Pharma Companies
article thumbnail

Listicle: Maximising outsourcing models beyond time and cost

Drug Discovery World

During a 2021 webinar on optimising assay development for hit identification, a survey asked over 50 drug discovery scientists, “Which goal is the highest priority when developing a drug discovery assay?”. Company Z would have to rely on the CRO for guidance and expertise. Opportunities, options, and outsourcing.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Srinivasan has led the development of multiple computational pipelines to process data from different next generation sequencing techniques with applications in oncology, genome editing systems including CRISPR-Cas mediated DNA editing, and ADAR-mediated RNA editing. big pharma or startups/spin off? What pro/cons?